瑞士2019-2020年产新德里金属β-内酰胺酶肠杆菌目细菌特征
108株测序分离株中NDM-1最常见(56株,主要为肺炎克雷伯菌),其次为NDM-5(49株,主要为大肠埃希菌);14株共产第二种碳青霉烯酶,近三分之一产16S rRNA甲基化酶。成功质粒和全球克隆是NDM在瑞士流行增加的主要因素。
要点
- 瑞士NDM阳性CPE以NDM-1和NDM-5为主,分别多见于肺炎克雷伯菌和大肠埃希菌。
- 近三分之一NDM阳性分离株产16S rRNA甲基化酶,导致氨基糖苷类全耐药。
- 成功质粒和全球克隆是NDM在瑞士传播增加的主要驱动因素。
核心结论
- NDM-1和NDM-5是瑞士2019-2020年NDM阳性CPE的主要变体,成功质粒和全球克隆促使其流行增加。
研究设计与样本
- 共分析141株分离株,其中108株进行了测序。
主要发现
- 141株中肺炎克雷伯菌59株、大肠埃希菌52株,超过50%来自筛查拭子。
- 108株测序株中NDM-1检出56株(肺炎克雷伯菌34/56),NDM-5检出49株(大肠埃希菌40/49)。
- 14株共产第二种碳青霉烯酶,以OXA-48样酶为主。
- 近三分之一分离株产16S rRNA甲基化酶,赋予氨基糖苷类全耐药。
临床怎么用
- 对碳青霉烯类耐药肠杆菌目细菌应关注NDM型别鉴定,尤其肺炎克雷伯菌和大肠埃希菌。
- 注意NDM阳性株可能共产OXA-48样酶和16S rRNA甲基化酶,影响抗菌药物选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Carbapenemase-producing Enterobacterales (CPE) bacteria are a critical global health concern; New Delhi metallo-β-lactamase (NDM) enzymes account for >25% of all CPE found in Switzerland. We characterized NDM-positive CPE submitted to the Swiss National Reference Center for Emerging Antibiotic Resistance during a 2-year period (January 2019-December 2020) phenotypically and by using whole-genome sequencing. Most isolates were either Klebsiella pneumoniae (59/141) or Escherichia coli (52/141), and >50% were obtained from screening swabs. Among the 108 sequenced isolates, NDM-1 was the most prevalent variant, occurring in 56 isolates, mostly K. pneumoniae (34/56); the next most prevalent was NDM-5, which occurred in 49 isolates, mostly E. coli (40/49). Fourteen isolates coproduced a second carbapenemase, predominantly an OXA-48-like enzyme, and almost one third of isolates produced a 16S rRNA methylase conferring panresistance to aminoglycosides. We identified successful plasmids and global lineages as major factors contributing to the increasing prevalence of NDMs in Switzerland.
引用
- Findlay J, Poirel L, Kessler J, et al. New Delhi Metallo-β-Lactamase-Producing Enterobacterales Bacteria, Switzerland, 2019-2020. Emerg Infect Dis. 2021. PMID: 34545787. doi:10.3201/eid2710.211265
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。